Horizon Pharma (NASDAQ: HZNP) announced the pricing of a previously announced underwritten secondary offering of 11,660,445 of its ordinary shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE